SpaceX Files for IPO Under Ticker SPCX Potentially Boosting Elon Musks Wealth to Trillionaire Status Japans Megabanks Record Profits Face Headwinds from Credit Costs and Geopolitical Risks Dollar Holds Near SixWeek High as Geopolitical Tensions Over Iran Stir Demand for Safe Havens Kevin Warshs Potential Fed Leadership Could Reshape Wall Streets Plumbing Understanding Offer for Sale OFS A Key Mechanism for Shareholders to Exit US Intensifies Efforts to Deploy American AI Across Asia Following TrumpXi Talks SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Efficiency Gains HST Q1 2026 Earnings Strong Earnings Beat Driven by Operational Leverage AM Q1 2026 Earnings EPS Misses Estimates Stock Declines 149 UTSI Q4 2019 Earnings EPS Misses Estimates by Wide Margin Revenue Not Disclosed CRIS Q1 2026 Earnings Significant EPS Miss Highlights Ongoing PreRevenue Challenges BAK Q1 2026 Earnings Massive EPS Beat Driven by Operational Efficiency and Favorable Margins Lionheart Holdings CUB Creeps Up Slightly Testing 1081 Amid Quiet Trading Avino Silver Gold Mines ASM Gains 25 as Precious Metals Sector Attracts Attention Lumen Technologies LUMN Surges 688 as Telecom Stock Tests Key Resistance Isabella Bank ISBA Slips Slightly Holds Above Key Support at 4089 CNB Financial CCNE Slips Marginally as Price Stays Between Key Support and Resistance Secure Waste Shareholders Approve Acquisition by GFL Environmental Buenaventura Mining Company Inc BVN Q4 2025 Earnings Massive EPS Beat on Strong Operational Performance Adamas Trust Senior Notes ADAMI Edge Lower as Price Hovers Near Midpoint of Range MGA Q1 2026 Earnings Strong EPS Beat of 33 Drives Positive Market Reaction PEBK Q4 2025 Earnings EPS of 121 Surpasses Absent Estimates Shares Edge Higher SUZ Q1 2026 Earnings Strong EPS Surprise Amid Market Concerns HCA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Steady Demand ASTH Q1 2026 Earnings EPS Misses Estimates Slight Stock Decline Faraday Future Intelligent Electric FFAI Q1 2026 Earnings Narrower Loss Surprises but Revenue Remains Absent TSHA Q1 2026 Earnings EPS Misses Estimates as Company Advances Gene Therapy Pipeline